Clinical Trial Update: Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating Egito Association for Type II diabetes mellitus and hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Egito Association

Snippet

Sponsor: EMS | Conditions: Hypertension Associated, Type II Diabetes Mellitus | Phase 3 | Status: WITHDRAWN